510(k) Report

FDA applicant

Neurologica Corporation

Danvers, MA8 decisions2005–20252 recalls

FDA records 8 decisions for Neurologica Corporation (Danvers, MA) from 2005 to 2025: 8 510(k) clearances. Most are in product codes JAK (System, X-Ray, Tomography, Computed) and KPS (System, Tomography, Computed, Emission). Since 2016 its 510(k)s took a median of 163 days from receipt to decision, against 136 for FDA’s reviews in the same codes and years. Its devices cite 15 predicates, 6 of them its own earlier devices. 2 recalls are linked to its devices.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, radiology panel, where it files most

How often FDA has decided Neurologica Corporation’s devices, and how often a recall has named them.

FDA decisions per year

1in 2025

2009: 12011: 12014: 12017: 12022: 12024: 12025: 1
2007high 1 (2009) · low 0 (2007)2026

2026 so far, outlined.

Recalls per year

1in 2023

2020: 12023: 1
2007high 1 (2020) · low 0 (2007)2026

Class I Class II/III not classified

FIG. 1 — Neurologica Corporation by year, 2007–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Neurologica Corporation’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report

Other applicant names beginning “Neurologica”

FDA records each applicant name separately; these may or may not be the same firm.